Lupin to market MSD's 23-valent Pneumococcal Polysaccharide Vaccine for India Hindu Business Line Adults with co morbid conditions like chronic lung disease, diabetes, chronic heart diseases, chronic liver diseases, immune compromised diseases as well as adults more than 65 years of age are at increased risk for pneumococcal diseases than healthy ... |
